Trenmademelikemen
Member
- Joined
- Sep 17, 2026
- Messages
- 50
- Online time
- 9h 55m
- Reputation
- 44
Two days ago the FDA approved a new selective FGFR2 inhibitor called lirafugratinib
Do you guys think this could surpass ERDA in terms of the maxillary benefits and craniofacial growth please dm if you have any info
Paper here
Do you guys think this could surpass ERDA in terms of the maxillary benefits and craniofacial growth please dm if you have any info
Paper here